Integrated Market Access

Solutions

A systematic approach

Reimbursed
Patient Access

We help biotech and pharmaceutical companies navigating pricing, reimbursement, and early access pathways to bring innovative therapies to BeNeLux patients in a sustainable way.

100%

Executional Excellence

+25 yrs

Experience

120+

Successful Submissions

3 Countries

BeNeLux Client Partnerships

How We Support Patient Access

Our expertise consists in navigating Pricing & Reimbursement, Guided Patient Access and Real-World Evidence

We demonstrate strategic engagement and executional excellence

with deep respect for the patient’s voice.

Bringing innovative medicines of pharmaceutical and biotech companies to patients, sustainably and meaningfully

Guided Patient Access

We deliver strategic, landscape-driven access planning that minimises delays and rejections, facilitates early stakeholder dialogue, and embeds patient priorities at the core of your access strategy.

Pricing & Reimbursement

We build localised value stories, providing end-to-end support from early access to reimbursement.

Real World Data

We design and implement Belgium-specific real-world evidence pilots, identifying the right registries and clinical partners while integrating meaningful patient-reported outcomes to strengthen your value proposition.

The Axes Health team

Dedicated to Patient Access

Pricing and reimbursement are complex
We Help You navigate

Leveraging deep insights into local healthcare systems, we develop robust pricing and reimbursement strategies.

Our Mission

Our Story

Cardiology

Nephrology

Haematology

Oncology

Respiratory

Neurology

Orphan Diseases

Dermatology

Therapeutic Domains

We bring extensive experience across a broad range of therapeutic domains

Why Choose Axes Health?

Deep respect for the patient's voice

Unmatched expertise in rare diseases.

Recognised executional excellence.

Respected partner by health authorities.

Execution & Launch

Following up on addressing clinical and budgetary uncertainties to maintain patient access.

Strategy Development

Defining the optimal pricing, access strategy and innovative contracting.

Strategy Development

Defining the optimal pricing, contracting, and access strategy for each target market.

Value Proposition

Crafting a compelling value story and gathering necessary clinical and economic evidence.

Landscape Assessment

An in-depth analysis of the current landscape, unmet needs, and payer perceptions.

Our Methodology

Integrated Market Access Solutions

A systematic approach ensuring no critical milestone is overlooked, from early-stage development to post-launch optimisation.

Reimbursed
Patient Access